Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Research Opportunities for Graduate Students These are some of the research opportunities available to students of the MPTP:

Cancer Pharmacology
  • Oncogenes and tumor suppressors
  • Cell cycle regulation
  • Mechanisms of DNA repair
  • Chemoprevention of cancer
  • Biomarkers for tumor progression

Cardiovascular and Renal Pharmacology

  • Regulation of blood pressure
  • Calcium and phosphate homeostasis
  • Vascular effects of reactive oxygen species

Drug Discovery
  • Design and development of high throughput drug screening methodologies
  • Novel chemotherapeutic agents
  • Combinatorial chemistry

  • Mechanisms of neurotoxicity
  • Regulation of ion channels
  • Regulation of the autonomic nervous system
  • Neuronal vesicle transport and mechanisms of synaptic transmission
  • Pharmacology of addiction

Pharmacology of Cell and Organ Systems

Signal Transduction

  • Structure and function of G protein coupled receptors
  • Signaling and cancer
  • Regulation of cellular processes by free radicals and nitric oxide derivatives
  • Nuclear receptors
  • Protein kinases and phosphatases


6/28/2019 9:00 AM Graduate Student Summer Seminar
Graduate Student Summer Seminar presented by Braulio Bonilla and Nolan Carew

Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings


Time to dissertation Defense
, last five graduating classes:  4.6 years, Completion Rate: 86.49%

First Author Publications (All students, past 5 year mean):  2.03;   Total Publications: 5.10

F-series Grants (F30/F31) (All Students, past 5 year mean):  12/34 (35%) 

Ranked #9 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty-four consecutive years

Back to Top